Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report

Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report

Inflammatory myofibroblastic tumor (IMT) is a very rare subtype of sarcoma, which frequently harbor chromosomal rearrangements, including anaplastic lymphoma kinase (ALK) rearrangements (almost 50% of the IMTs) and other kinase fusions such as ROS1. ROS1 fusions are present in about 10% of IMT, almo...

Full description

Bibliographic Details
Main Authors: Danila Comandini, Fabio Catalano, Massimiliano Grassi, Guido Pesola, Rossella Bertulli, Antonio Guadagno, Bruno Spina, Matteo Mascherini, Franco De Cian, Federico Pistoia, Sara Elena Rebuzzi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
inflammatory myofibroblastic tumor
inflammatory pseudotumor
sarcoma
ROS1
crizotinib
retreatment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.658327/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.658327/full

Similar Items